6 completed. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
Follow Dermatitis, Irritant: new trials by email Literature Review of Dermatitis, Irritant trials Research Report on Dermatitis, Irritant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects KX01 ointment 1%, Placebo ointment - Healthy Volunteer | Phase 1 | Completed | PharmaEssentia | 20 | 2021-11-16 | 2022-02-18 |
| Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream MC2-01 Cream, irradiation, MC2-01 Cream, no irradiation, MC2-01 vehicle, irradiation - Phototoxicity | Phase 1 | Completed | MC2 Therapeutics | 35 | 2019-02-27 | 2020-02-12 |
| TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light TMC435, Placebo, Ciprofloxacin - Hepatitis C Virus | Phase 1 | Completed | Tibotec Pharmaceuticals, Ireland | 49 | 2010-07-01 | 2013-05-06 |
| A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers Tazarotene Foam without irradiation, Tazarotene Foam with UVA and UVB irradiation, Tazarotene Foam with UVA, UVB, and visible light - Acne Vulgaris | Phase 1 | Completed | Stiefel, a GSK Company | 38 | 2010-04-01 | 2017-06-20 |
| Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment Xenaderm, Placebo - Healthy | Phase 1 | Completed | Healthpoint | 38 | 2008-02-01 | 2014-01-13 |
| Clinical Evaluation of the Photoallergy Potential of Atralin Gel Atralin (tretinoin) gel, 0.05% - Healthy | Phase 1 | Completed | Coria Laboratories, Ltd. | 40 | 2008-01-01 | 2008-05-06 |
Dermatitis, Phototoxic (6) · Acne Vulgaris (1) · Hepatitis C (1) · Photosensitivity Disorders (1)
Dermatitis (6) · Dermatitis, Contact (6) · Skin Diseases (6) · Skin Diseases, Eczematous (6) · Skin and Connective Tissue Diseases (6) · Photosensitivity Disorders (5) · Acneiform Eruptions (1) · Blood-Borne Infections (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Flaviviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Infections (1)
Radiation (2) · Ciprofloxacin (1) · Gels (1) · Granulex (1) · Light (1) · Simeprevir (1) · Tretinoin (1)
Coria Laboratories, Ltd. (1) · Healthpoint (1) · MC2 Therapeutics (1) · PharmaEssentia (1) · Stiefel, a GSK Company (1) · Tibotec Pharmaceuticals, Ireland (1)
United States (3) · Japan (1)
Hisakuni Sekino (1) · Innes Cargill, PhD (1) · Jonathan S Dorsik (1) · Joseph W Stanfield, MS (1)